Results 101 to 110 of about 2,270 (175)

Follow-up study of vonoprazan maintenance therapy for reflux esophagitis: A 96-week evaluation in patients with PPI-refractory disease. [PDF]

Biomed Rep
Mizuno H, Inagaki S, Yamada K, Kamiyamamoto S.   +3 more
europepmc   +1 more source

Endoscopic Treatment of Gastric Neuroendocrine Tumors: What's Next? [PDF]

Gut Liver
Kim I, Cho YK.
europepmc   +1 more source

Last decade of advances in gastric neuroendocrine tumors: Innovations, challenges, and future directions. [PDF]

World J Clin Oncol
Christodoulidis G, Kouliou MN, Ragias D, Chatziisaak D, Agko ES, Schizas D, Zacharoulis D.   +6 more
europepmc   +1 more source

Severe Recurrent Gastrointestinal Bleeding and Diagnostic Dilemmas in Zollinger-Ellison Syndrome: A Case Report. [PDF]

GE Port J Gastroenterol
Bragança S, Figueiredo LM, Oliveira AM, Padrão C, Costa MN, Horta D.   +5 more
europepmc   +1 more source

Effects of Medication Period and Gastrin Levels on Endoscopic Gastric Mucosal Changes in Long-Term Proton Pump Inhibitor Users. [PDF]

Diagnostics (Basel)
Suda H, Sakurai K, Eto S, Fujie S, Okuda A, Takeichi T, Urata M, Murao T, Hasuda K, Hirano M, Kato Y, Haruma K.   +11 more
europepmc   +1 more source

Co-occurrence of Gastric Xanthoma and Numerous Large Hyperplastic Polyps as a Complication of Argon Plasma Coagulation in GAVE. [PDF]

ACG Case Rep J
Poltiyelova E, Balassiano N, Eskaros SL.
europepmc   +1 more source

Context matters: Causality and global epidemiology of proton pump inhibitor safety. [PDF]

PLoS Med
Okabayashi S, Kaplan GG.
europepmc   +1 more source

Over-the-Counter Ibuprofen-Induced Pre-Pyloric Gastric Perforation in a 28-Month-Old Child: A Rare Pediatric Case. [PDF]

Cureus
Uddin W, Aylan Alshamsi M, Gupta V, Alblooshi M, Abdul Kader M.   +4 more
europepmc   +1 more source

Distinguishing second primary tumors from local recurrence in type 1 gastric neuroendocrine tumors: a risk-stratified management strategy. [PDF]

Surg Endosc
Jin J, Zhang H, Ding S, Zhang J.
europepmc   +1 more source

Risks of anti-<i>Helicobacter</i> therapy and long-term therapy with antisecretory drugs. [PDF]

World J Gastroenterol
Kotelevets SM.
europepmc   +1 more source